HIV-1 viral load monitoring: an opportunity to reinforce treatment adherence in a resource-limited setting in Thailand

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 103, Issue 6, 2009, Pages 601-606

  Wilson, David ^a   Keiluhu, A Kace ^a   Kogrum, Suphawadee ^a   Reid, Tony ^b   Seriratana, Noppadol ^c   Ford, Nathan ^a   Kyawkyaw, Moe ^a   Talangsri, Phol ^d   Taochalee, Nattayapa ^d  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b MÉDECINS SANS FRONTIÈRES   (Belgium)

^c Kuchinarai Crown Prince Hospital   (Thailand)

^d Kuchi Friends' ^*  (Thailand)

Author keywords

Highly active antiretroviral therapy; HIV 1; Psychosocial support; Resource limited settings; Treatment adherence; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; EFAVIRENZ PLUS LAMIVUDINE PLUS STAVUDINE; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; STAVUDINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHILD; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MONITORING; NONHUMAN; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PRIMARY HEALTH CARE; PSYCHOSOCIAL CARE; PSYCHOSOCIAL DISORDER; PUBLIC HOSPITAL; RURAL AREA; THAILAND; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; COUNSELING; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MEDICATION ADHERENCE; NEEDS ASSESSMENT; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PROGRAM DEVELOPMENT; THAILAND; VIRAL LOAD; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 67349096065     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.11.007     Document Type: Article

References (18)

1. WHO/UNAIDS/UNICEF. Towards Universal Access Scaling up Priority HIV/AIDS Interventions in the Health Sector: Progress Report June 2008. Geneva: World Health Organization; 2008. http://www.who.int/hiv/pub/towards_universal_access_report_2008.pdf [accessed 30 October 2008].
2. Wainberg M.A., and Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 279 (1998) 1977-1983
3. Boden D., Hurley A., Zhang L., Cao Y., Guo Y., Jones E., et al. HIV-1 drug resistance in newly infected individuals. JAMA 282 (1999) 1135-1141
4. Schooley R. Viral load testing in resource-limited settings [editorial comment]. Clin Infect Dis 44 (2007) 139-140
5. WHO. Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: recommendations for a public health approach (2006), World Health Organization, Geneva
6. Coetzee D., Boulle A., Hildebrand K., Asselman V., van Cutsem G., and Goemaere E. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS 18 (2004) S27-S31
7. Orrell C., Harling G., Lawn S.D., Kaplan R., McNally M., Bekker, et al. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited. Antivir Ther 12 (2007) 83-88
8. Calmy A., Ford N., Hirschel B., Reynolds S.J., Lynen L., Goemaere E., et al. HIV viral load monitoring in resource-limited regions: optional or necessary?. Clin Infect Dis 44 (2007) 128-134
9. Liu H., Golin C.E., Millar L.G., Hays R.D., Beck C.K., Sanandaji S., et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 134 (2001) 968-977
10. Calmy A., Pinoges L., Szumilin E., Zachariah R., Ford N., and Ferradini L. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS 20 (2004) 1163-1169
11. Lee P.K., Kieffer T.L., Siliciano R.F., and Nettles R.E. HIV-1 viral load blips are of limited clinical significance. J Antimicrob Chemother 57 (2006) 803-805
12. Nettles R.E., Kieffer T.L., Kwon P., Monie D., Han Y., Parsons T., et al. Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART. JAMA 293 (2005) 817-829
13. Jonesa L.E., and Perelson A.S. Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART. Bull Math Biol 67 (2005) 1227-1251
14. DHSS. A Guide To Primary Care for People With HIV/AIDS. Health Resources and Services Administration Information Center, VA. US Dept of Health and Human Services; 2004. http://hab.hrsa.gov/tools/primarycareguide/ [accessed 30 October 2008].
15. Stone V.E., Hogan J.W., Schuman P., Rompalo A.M., Howard A.A., Korkontzelou C., et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr 28 (2001) 124-131
16. Over M., Revenga A., Masaki E., Peerapatanapokin W., Gold J., Tangcharoensathien V., and Thanprasertsuk S. The economics of effective AIDS treatment in Thailand. AIDS 21 (2007) S105-S116
17. Phillips A.N., Pillay D., Miners A.H., Bennett D.E., Gilks C.F., and Lundgren J.D. Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model. Lancet 371 (2008) 1443-1451
18. Lawn S., Bekker L.-G., Calmy A., and Wood R. Monitoring of antiretroviral therapy in low-resource settings. Lancet 372 (2008) 287-288